Lipsker D, Heid E, Grosshans E, Cribier B
Clinique Dermatologique des Hôpitaux Universitaires de Strasbourg.
Ann Dermatol Venereol. 1998 Apr;125(4):241-6.
The incidence of melanoma has increased more than the incidence of any other cancer in the past twenty years. There is no cure for advanced-staged melanoma and it's early diagnosis has become a main issue of health policy. Therefore, precise epidemiological data are needed. These data depend on the geographical setting and very few data are available for France. We studied these data in Strasbourg.
All patients hospitalized for melanoma between 1960 and 1989 at the academic dermatology department, Strasbourg, were included in this retrospective, monocentric, study. The diagnosis of melanoma was confirmed in all cases by a dermatopathologist. Clinical, histopathologic and epidemiological data of the patients were recorded.
Six hundred seventeen patients with a mean age of 52 years were included. The number of new patients hospitalized for melanoma grew steadily. The mean tumor thickness was 2.31 mm (+/- 1.59) and it remained unchanged between 1970 and 1989. The mean duration between the first clinical signs of melanoma and excision of the tumor was 22 months. Only 4 p. 100 of the melanomas were diagnosed by means of routine examination, and this concerned almost exclusively patients hospitalized after 1980. Eighty five p. 100 of the patients had localized melanoma (stage I) at time of diagnosis. Forty two p. 100 of the patients developed metastasis. The mean five year survival rate was 68 p. 100.
The number of new patients hospitalized each year for melanoma grew steadily, but the mean tumor thickness remained unchanged. This indicates that the ratio "thick"/"thin" melanomas has remained unchanged between 1960 and 1989 and that the number of melanomas of any thickness has increased. Clinical data show an unawareness of the local population of the dangers of pigmented lesions during the reference period. This unawareness can be partially explained by the fact that no specific information campaign has ever taken place in this area. These data suggest that such a campaign should be recommended.
在过去二十年中,黑色素瘤的发病率增长幅度超过了其他任何癌症。晚期黑色素瘤无法治愈,其早期诊断已成为卫生政策的一个主要问题。因此,需要精确的流行病学数据。这些数据因地理环境而异,而法国可获得的数据很少。我们在斯特拉斯堡对这些数据进行了研究。
本回顾性单中心研究纳入了1960年至1989年期间在斯特拉斯堡学术皮肤科住院的所有黑色素瘤患者。所有病例的黑色素瘤诊断均由皮肤病理学家确认。记录了患者的临床、组织病理学和流行病学数据。
共纳入617例患者,平均年龄52岁。因黑色素瘤住院的新患者数量稳步增长。平均肿瘤厚度为2.31毫米(±1.59),在1970年至1989年间保持不变。黑色素瘤首次出现临床症状至肿瘤切除的平均时间为22个月。只有4%的黑色素瘤是通过常规检查诊断出来的,而且几乎都是1980年以后住院的患者。85%的患者在诊断时患有局限性黑色素瘤(I期)。42%的患者发生了转移。平均五年生存率为68%。
每年因黑色素瘤住院的新患者数量稳步增长,但平均肿瘤厚度保持不变。这表明,1960年至1989年间,“厚”/“薄”黑色素瘤的比例保持不变,且任何厚度的黑色素瘤数量均有所增加。临床数据显示,在参考期间当地居民对色素沉着病变的危险性认识不足。这种认识不足可以部分归因于该地区从未开展过具体的宣传活动。这些数据表明,应该开展这样的宣传活动。